Turning Leaf Counseling, Inc - Medicare Mental Health Clinic in Mason City, IA

Turning Leaf Counseling, Inc is a medicare enrolled mental health clinic (Counselor - Mental Health) in Mason City, Iowa. The current practice location for Turning Leaf Counseling, Inc is 103 E State St Ste 301, Mason City, Iowa. For appointments, you can reach them via phone at (641) 903-9949. The mailing address for Turning Leaf Counseling, Inc is 103 E State St Ste 301, Mason City, Iowa and phone number is (641) 903-9949.

Turning Leaf Counseling, Inc is licensed to practice in Iowa (license number 001039). The clinic also participates in the medicare program and its NPI number is 1417367400. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (641) 903-9949.

Contact Information

Turning Leaf Counseling, Inc
103 E State St Ste 301
Mason City
IA 50401-3309
(641) 903-9949
Not Available

Mental Health Clinic Profile

Full NameTurning Leaf Counseling, Inc
SpecialityCounselor
Location103 E State St Ste 301, Mason City, Iowa
Authorized Official Name and PositionCody Alan Williams (PRESIDENT/EXC. CLINICIAN)
Authorized Official Contact6419039949
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Turning Leaf Counseling, Inc
103 E State St Ste 301
Mason City
IA 50401-3309

Ph: (641) 903-9949
Turning Leaf Counseling, Inc
103 E State St Ste 301
Mason City
IA 50401-3309

Ph: (641) 903-9949

NPI Details:

NPI Number1417367400
Provider Enumeration Date04/30/2014
Last Update Date11/23/2020
Certification Date11/23/2020

Medicare PECOS Information:

Medicare PECOS PAC ID9537479563
Medicare Enrollment IDO20151104000070

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Turning Leaf Counseling, Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417367400NPI-NPPES
001039OtherIASTATE LICENSURE BUREAU

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health 001039 (Iowa)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Turning Leaf Counseling, Inc acts as a billing entity for following providers:
Provider NameLindsey L Craighton
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1295701514
PECOS PAC ID: 9234328345
Enrollment ID: I20110105000511

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NamePaula K Linnevold
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1992812044
PECOS PAC ID: 0840462347
Enrollment ID: I20111005000459

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameRaymond T Lang
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1629086186
PECOS PAC ID: 6406028869
Enrollment ID: I20111006000301

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameShelby R Allen-benitz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1174759666
PECOS PAC ID: 3375799414
Enrollment ID: I20120806000804

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameAdam K Lewis
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1871963686
PECOS PAC ID: 7012297740
Enrollment ID: I20161214002461

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameRandi R Gambell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1760849467
PECOS PAC ID: 4688006992
Enrollment ID: I20191107000165

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameJillian Kay Carpenter
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1982069035
PECOS PAC ID: 5991112518
Enrollment ID: I20210329000096

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameEmily A Ehlke
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1942868955
PECOS PAC ID: 6709272834
Enrollment ID: I20220329002792

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameAmie J Otto
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336440015
PECOS PAC ID: 0648451617
Enrollment ID: I20220330000224

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NamePorsha S Isbell
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1174140040
PECOS PAC ID: 8426406133
Enrollment ID: I20231117002987

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameDebra L Mcgee
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1548829989
PECOS PAC ID: 1153779863
Enrollment ID: I20231117002990

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameMichelle Boldt
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1538768593
PECOS PAC ID: 8123476728
Enrollment ID: I20231120003234

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameJessica Tomke
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1619456282
PECOS PAC ID: 9739537341
Enrollment ID: I20231120003415

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameSarah L Morrison
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1770876005
PECOS PAC ID: 1850749375
Enrollment ID: I20231122000522

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameChristopher L Seger
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1801909155
PECOS PAC ID: 0446608640
Enrollment ID: I20231129000727

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameLeslie S Sloan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700667458
PECOS PAC ID: 3072961135
Enrollment ID: I20231129003454

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameMichaela F Egesdal
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1295339687
PECOS PAC ID: 9638527740
Enrollment ID: I20231130001363

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameCody Williams
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1386811990
PECOS PAC ID: 6709196736
Enrollment ID: I20231206003913

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

Provider NameKatherine L Seger
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1548704695
PECOS PAC ID: 9739538489
Enrollment ID: I20231207000749

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 4 days ago

News Archive

Leader of Scotland's doctors address to annual conference of BMA

Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

Roundup: Ore. Gov. suggests malpractice reform; Mass. Gov. proposes new scrutiny for health care providers; Texas has offered HPV vaccine since 2007

The state can cut health care costs and reduce the number of medical-related lawsuits by requiring earlier notification of injuries as well as pretrial mediation, according to a recommendation Gov. John Kitzhaber issued Wednesday. The product of closed-door talks between representatives of interest groups including the Oregon Medical Association and the Oregon Trial Lawyers Association, Kitzhaber's recommendation now goes to a work group including lawmakers, a trial lawyer and doctor that begins public meetings next week.

Utah-based company licenses new biomedical device from BYU for chronic back pain

In between the vertebrae of the human spine are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together and allow for spine movement. While the discs are critical for movement, they can become the source of back pain when they degenerate or herniate - a major health problem that affects 85% of Americans and drains the U.S. economy to the tune of $100 billion every year.

Antibody-dependent enhancement

Some viruses' ability to exploit the human body's own defenses to increase their replication may be both a blessing and curse, according to the findings of a study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

Read more News

› Verified 4 days ago

Counselor in Mason City, IA

Avalon Center
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 22 N Georgia Ave, Suite #102, Mason City, IA 50401
Phone: 641-422-0070    Fax: 641-422-0060
Lindstrom Family Practice P.c.
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1327 6th Sw, Mason City, IA 50401
Phone: 641-423-0711    Fax: 641-423-0713
Mood Food Wellness
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 520 S Pierce Ave Ste 213, Mason City, IA 50401
Phone: 641-426-0650    
Good Shepherd Geriatric Center, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 302 2nd St Ne, Mason City, IA 50401
Phone: 641-424-1740    
Parents United Of North Central Iowa, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 600 1st St Nw Ste 107, Mason City, IA 50401
Phone: 541-424-5232    Fax: 641-424-8141
Lancaster Counseling Services Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 202 1st St Se Ste 103, Mason City, IA 50401
Phone: 641-420-1637    
Mercy Phychiatric Physicians
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1000 4th St Sw, Suite Psy, Mason City, IA 50401
Phone: 641-422-7797    Fax: 641-422-7516

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.